Web Results

en.wikipedia.org/wiki/Omalizumab

Omalizumab, sold under the trade name Xolair, is a medication originally designed to reduce sensitivity to allergens. It has been used to try to control severe ...

www.rxlist.com/xolair-drug.htm

Learn about Xolair (Omalizumab) may treat, uses, dosage, side effects, drug interactions, warnings, patient labeling, reviews, and related medications.

www.xolair.com/allergic-asthma/how-xolair-works.html

XOLAIR(R)(omalizumab) for subcutaneous use is an injectable prescription medicine ... Do not receive XOLAIR if you are allergic to omalizumab or any of the  ...

www.xolair.com

XOLAIR® (omalizumab) is a treatment for moderate to severe persistent allergic asthma and Chronic Idiopathic Urticaria (CIU) in appropriate patients.

www.medscape.com/viewarticle/494543

Results: Omalizumab is a monoclonal antibody targeting the high-affinity receptor binding site on human immunoglobulin (Ig)E. Bound IgE is not available for ...

reference.medscape.com/drug/xolair-omalizumab-343444

Medscape - Allergic asthma and chronic idiopathic urticaria dosing for Xolair( omalizumab), frequency-based adverse effects, comprehensive interactions, ...

medlineplus.gov/druginfo/meds/a603031.html

Feb 15, 2015 ... Omalizumab Injection: learn about side effects, dosage, special precautions, and more on MedlinePlus.

www.medicinenet.com/omalizumab/article.htm

May 15, 2017 ... Information about omalizumab (Xolair), an injectable drug prescribed to treat asthma that is not adequately controlled with inhaled steroids.

www.nejm.org/doi/full/10.1056/NEJMct055184

Jun 22, 2006 ... Clinical Therapeutics from The New England Journal of Medicine — Omalizumab for Asthma.

www.ncbi.nlm.nih.gov/pmc/articles/PMC1681435

Jan 27, 2005 ... Results. Omalizumab is a monoclonal antibody targeting the high-affinity receptor binding site on human immunoglobulin (Ig)E. Bound IgE is ...